VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,960,000 | +538.3% | 500,000 | +733.3% | 0.03% | +560.0% |
| Q4 2017 | $1,247,000 | -97.5% | 60,000 | -98.3% | 0.01% | -97.8% |
| Q3 2017 | $50,155,000 | +5698.3% | 3,500,000 | +6900.0% | 0.22% | +4380.0% |
| Q2 2017 | $865,000 | -78.2% | 50,000 | -86.1% | 0.01% | -77.3% |
| Q1 2017 | $3,960,000 | -79.3% | 359,000 | -72.8% | 0.02% | -83.6% |
| Q4 2016 | $19,166,000 | -87.1% | 1,320,000 | -78.2% | 0.13% | -87.2% |
| Q3 2016 | $148,560,000 | +40.1% | 6,051,300 | +14.9% | 1.04% | +44.9% |
| Q2 2016 | $106,025,000 | -1.8% | 5,264,400 | +28.3% | 0.72% | -12.9% |
| Q1 2016 | $107,948,000 | +5831.2% | 4,104,500 | +22830.2% | 0.83% | +5420.0% |
| Q4 2015 | $1,820,000 | -80.9% | 17,900 | -58.3% | 0.02% | -77.3% |
| Q2 2015 | $9,530,000 | -49.7% | 42,900 | -67.6% | 0.07% | -50.4% |
| Q4 2014 | $18,933,000 | -90.9% | 132,300 | -91.6% | 0.13% | -91.5% |
| Q3 2014 | $207,309,000 | +7.5% | 1,580,100 | +3.4% | 1.56% | +26.2% |
| Q2 2014 | $192,788,000 | – | 1,528,606 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |